Skip to main content

Table 2 Imbalance of patient characteristics before and after propensity score matching in the assessment of delirium

From: Association between statin use on delirium and 30-day mortality in patients with chronic obstructive pulmonary disease in the intensive care unit

Item

n

Unmatched

SMD

Matched

SMD

Non-statins

Statins

SMD

− 0.1

Non-statins

Statins

SMD

− 0.1

1241

1484

  

955

955

  

Age (year)

69.46 (11.77)

73.12 (9.80)

0.338

 > 0.1

71.56 (11.38)

71.54 (9.58)

0.002

< 0.1

SBP (mmHg)

116.61 (15.63)

117.41 (16.35)

0.05

 < 0.1

117.03 (15.40)

117.40 (16.22)

0.023

< 0.1

DBP (mmHg)

63.14 (10.99)

60.91 (10.59)

0.207

 > 0.1

62.22 (10.69)

62.15 (10.78)

0.006

< 0.1

HR (beats/min)

87.74 (16.36)

84.37 (14.75)

0.216

 > 0.1

86.22 (15.95)

85.90 (15.38)

0.021

< 0.1

SpO2 (%)

96.16 (2.34)

96.18 (2.20)

0.008

 < 0.1

96.15 (2.35)

96.18 (2.15)

0.009

< 0.1

Asthma

55 (4.4)

59 (4.0)

0.023

 < 0.1

45 ( 4.7)

47 (4.9)

0.01

< 0.1

CAD

117 (9.4)

339 (22.8)

0.371

 > 0.1

111 (11.6)

119 (12.5)

0.026

< 0.1

Liver disease

219 (17.6)

95 ( 6.4)

0.351

 > 0.1

85 (8.9)

87 (9.1)

0.007

< 0.1

Malignant cancer

255 (20.5)

191 (12.9)

0.207

 > 0.1

165 (17.3)

155 (16.2)

0.028

< 0.1

PLT (109/L)

225.28 (114.45)

227.34 (99.49)

0.019

 < 0.1

229.06 (108.70)

230.91 (105.12)

0.017

< 0.1

HGB (g/L)

11.46 (2.26)

11.26 (2.10)

0.094

 < 0.1

11.38 (2.22)

11.42 (2.13)

0.018

< 0.1

Calcium (mg/dL)

8.58 (0.81)

8.64 (0.69)

0.076

 < 0.1

8.62 (0.80)

8.61 (0.69)

0.012

< 0.1

Sodium (mmol/L)

139.55 (5.27)

139.73 (4.64)

0.036

 < 0.1

139.70 (4.87)

139.72 (4.60)

0.005

< 0.1

Glucose (mg/dL)

169.56 (96.72)

177.37 (104.89)

0.077

 < 0.1

170.52 (100.27)

172.39 (92.73)

0.019

< 0.1

Glucocorticoid

483 (38.9)

485 (32.7)

0.13

 > 0.1

355 (37.2)

355 (37.2)

< 0.001

< 0.1

Antibiotic

1073 (86.5)

1207 (81.3)

0.14

 > 0.1

802 (84.0)

804 (84.2)

0.006

< 0.1

Norepinephrine

238 (19.2)

337 (22.7)

0.087

 < 0.1

202 (21.2)

188 (19.7)

0.036

< 0.1

Epinephrine

56 (4.5)

74 (5.0)

0.022

 < 0.1

47 (4.9)

40 (4.2)

0.035

< 0.1

Vasopressin

114 (9.2)

170 (11.5)

0.075

 < 0.1

102 (10.7)

88 (9.2)

0.049

< 0.1

ACEI/ARB

122 (9.8)

294 (19.8)

0.284

 > 0.1

117 (12.3)

124 (13.0)

0.022

< 0.1

SAPII

40.39 (14.03)

39.28 (11.58)

0.087

 < 0.1

39.81 (13.40)

39.74 (12.17)

0.006

< 0.1

OASIS

35.51 (9.39)

33.29 (8.46)

0.249

 > 0.1

34.47 (9.08)

34.47 (8.60)

< 0.001

< 0.1

Los-ICU

6.01 (6.45)

5.10 (5.45)

0.152

 > 0.1

5.51 (5.99)

5.55 (6.16)

0.006

< 0.1

  1. An absolute MSD < 10% was considered to support the assumption of a balance between the groups. SMD: standardized mean differences. Data are presented as medians [interquartile ranges], mean [SD] or as numbers (percentages)
  2. SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, CAD coronary artery disease, CVD cerebrovascular disease, RR respiratory rate, HGB hemoglobin, WB white blood cell count, ACEI/ARB angiotensin-converting enzyme inhibitors/angiotensin II inhibitors, SAPS II Simplified Acute Physiology Score, OASIS Oxford Acute Severity of Illness Score, Los length of stay